Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Clin J Am Soc Nephrol. 2006 Nov;1(6):1322-30. doi: 10.2215/CJN.03060906. Epub 2006 Oct 11. Clin J Am Soc Nephrol. 2006. PMID: 17699365
Treatment of relapsed and refractory multiple myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Curr Treat Options Oncol. 2003 Jun;4(3):229-37. doi: 10.1007/s11864-003-0024-9. Curr Treat Options Oncol. 2003. PMID: 12718800 Review.
Novel therapies in multiple myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Int J Hematol. 2003 Apr;77(3):226-31. doi: 10.1007/BF02983778. Int J Hematol. 2003. PMID: 12731664 Review.
Bortezomib-induced tumor lysis syndrome in multiple myeloma.
Sezer O, Vesole DH, Singhal S, Richardson P, Stadtmauer E, Jakob C, Boral AL, Esseltine DL, Mehta J. Sezer O, et al. Among authors: mehta j. Clin Lymphoma Myeloma. 2006 Nov;7(3):233-5. doi: 10.3816/CLM.2006.n.064. Clin Lymphoma Myeloma. 2006. PMID: 17229340 Clinical Trial.
Lenalidomide in myeloma.
Singhal S, Mehta J. Singhal S, et al. Among authors: mehta j. Curr Treat Options Oncol. 2007 Apr;8(2):154-63. doi: 10.1007/s11864-007-0011-7. Curr Treat Options Oncol. 2007. PMID: 17713723 Review.
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Stadtmauer EA, Lonial S, Vesole DH, Abonour R, Alsina M, Badros A, Comenzo R, Durie B, Giralt S, Hussein M, Jakubowiak A, Mehta J, Niesvizky R, Orlowski R, Siegel D, Singhal S, Vescio R, Wang M, Zangari M, Munshi NC. Stadtmauer EA, et al. Among authors: mehta j. Clin Adv Hematol Oncol. 2007 Oct;5(10 Suppl 15):7-19, quiz 21-2. Clin Adv Hematol Oncol. 2007. PMID: 18000495 No abstract available.
Instability of immunophenotype in plasma cell myeloma.
Cao W, Goolsby CL, Nelson BP, Singhal S, Mehta J, Peterson LC. Cao W, et al. Among authors: mehta j. Am J Clin Pathol. 2008 Jun;129(6):926-33. doi: 10.1309/8UVF7YQ1D4D4ETQV. Am J Clin Pathol. 2008. PMID: 18480010
How I treat elderly patients with myeloma.
Mehta J, Cavo M, Singhal S. Mehta J, et al. Blood. 2010 Sep 30;116(13):2215-23. doi: 10.1182/blood-2009-10-163329. Epub 2010 Jul 19. Blood. 2010. PMID: 20644120 Free article.
2,464 results